Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II)
Girvan Burnside,
Munir Pirmohamed,
Anthony Guy Marson,
John Paul Leach,
Gus Baker,
Catrin Tudur-Smith,
Richard Appleton,
Silviya Balabanova,
Graeme Sills,
Catrin Plumpton
Affiliations
Girvan Burnside
3 Clinical Trials Research Centre, The University of Liverpool, Liverpool, UK
Munir Pirmohamed
10 Department of Pharmacology, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK
Anthony Guy Marson
1 Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
John Paul Leach
7 School of Medicine, University of Glasgow, Glasgow, UK
Gus Baker
1 Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
Catrin Tudur-Smith
Institute of Translational Medicine, University of Liverpool Institute of Translational Medicine, Liverpool, UK
Richard Appleton
Department of Neurology, Alder Hey Children's NHS Foundation Trust, Liverpool, Merseyside, UK
Silviya Balabanova
1 Liverpool Clinical Trials Centre, University of Liverpool, Faculty of Health and Life Sciences, Liverpool, UK
Graeme Sills
2 School of Life Sciences, University of Glasgow, Glasgow, UK
Catrin Plumpton
4 Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK